Abstract:For both in situ or ex situ regeneration of tissues to be repaired,an ideal tissue engineering scaffold should create a local environment to facilitate homing,induced differentiation,and proliferation in addition to its molding function.For a tissue engineering scaffold to achieve this objective,releasing the relevant cell growth factors for sufficient period of time is more efficient and natural over that by material morphology.However,protein drugs are delicate and easily denatured by the harsh conditions of preparation for tissue engineering scaffolds,which may evoke undesirable antibody responses.None of the tissue engineering scaffolds reported to date have achieved long-term sustained-release of cell growth factor proteins in native conformation.To overcome this still-standing hurdle,the present study demonstrated a method to load cytokine proteins into tissue-engineering fibers with preserved native conformation for achieving long term sustained-release.We first preloaded vascular endothelial growth factor (VEGF165) as the model protein into dextran nanoparticles without contacting water-oil or water-gas interface (recognized protein conformation killer) by utilizingthe freezing induced aqueous phase separation method developed in our lab.Then the VEGF165 protected in the matrix of dextran particles were suspended in a solution of poly (lactic-co-glycolic acid) (PLGA) prior to electrospinning to form fibers.In order to avoid burst release in the initial stage by the protein-preloaded particles exposed at the fiber surface,another layer of PLGA fiber which carried no VEGF165 was spanned on the top of the already formed PLGA fiber membrane.A series of physicochemical characterizations comprising scanning electron microscopy (SEM),contact angle,mechanical strength,confirmed that the tissue engineering fibers formed above possessed satisfied surface texture and mechanical strength.The VEGF165 was recovered after each of the preparation step and assayed using CCK-8 test for bioactivity.The results indicated that the VEGF165 recovered from the dextran nanoparticles retained＞97 ％ bioactivity,and that from the final fiber was above 87 ％,both were remarkably higher than that recovered from the fibers formed in which the protein was preloaded in solution form (＜55 ％).In vitro release test showed that nanoparticles composite fibers prepared as above achieved a sustained-release profile with minimal initial burst and un-released residue.The protein was released less than 35 ％ of the total load in the initial five days and over 92％ at day 25.For the fibers wherein VEGF16s was loaded in the solution form,the 53.12 ％ of protein load was released in the initial five days,and 84.52 ％ was released at day 25.The therapeutic efficacy of the VEGF165 loaded fiber membranes were examined on the rat model of lowerlimb ischemia,followed immunohistochemistry observation.The results indicated that the regenerated blood vessels by dextran nanoparticles composite PLGA fibers were significantly more than that by the fibers to which VEGF165 was loaded in solution form.As conclusion,pre-loading proteins in polysaccharide nanoparticles prior to electrospinning was an effective method to prepare efficacious tissue engineere fibers for sustained-release cell growth factored with preserved bioactivity and improved release kinetics.

Encapsulation of Proteinase K in PELA Ultrafine Fibers by Emulsion Electrospinning: Preparation and in Vitro Evaluation

Self-accelerated biodegradation of electrospun poly(ethylene glycol)–poly(l-lactide) membranes by loading proteinase K

Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes.

Encapsulation and controlled release of lysozyme from electrospun poly(ε-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme–oleate complexes

Encapsulating Drugs in Biodegradable Ultrafine Fibers Through Co-Axial Electrospinning

A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents.

Preparation of Coaxial-Electrospun Poly[bis(p-methylphenoxy)]phosphazene Nanofiber Membrane for Enzyme Immobilization

Modulation of Protein Release from Biodegradable Core-Shell Structured Fibers Prepared by Coaxial Electrospinning.

Structural Stability and Release Profiles of Proteins from Core-Shell Poly (Dl-Lactide) Ultrafine Fibers Prepared by Emulsion Electrospinning

Encapsulation of Proteins in Poly(l-Lactide-co-caprolactone) Fibers by Emulsion Electrospinning

A Novel System for Water Soluble Protein Encapsulation with High Efficiency: “micelles Enhanced” Polyelectrolyte Capsules

Encapsulation of Drug Reservoirs in Fibers by Emulsion Electrospinning: Morphology Characterization and Preliminary Release Assessment

Diverse Release Behaviors of Water-Soluble Bioactive Substances from Fibrous Membranes Prepared by Emulsion and Suspension Electrospinning.

In situ encapsulation of laccase in microfibers by emulsion electrospinning: preparation, characterization, and application.

Electrospun PELCL Membranes Loaded with QK Peptide for Enhancement of Vascular Endothelial Cell Growth

Encapsulation of Proteins in PLGA Fibers by Emulsion Electrospinning

Preparation of PVA/PEI Ultra-Fine Fibers and Their Composite Membrane with PLA by Electrospinning

Emulsion Electrospinning of Nanofibrous Delivery Vehicles for the Controlled Release of Biomolecules and the in Vitro Release Behaviour of Biomolecules

Preparation and Protein Sustained-release System of Electrospinning Nanofibers

Preparation of Porous Core–Shell Poly L-Lactic Acid/Polyethylene Glycol Superfine Fibres Containing Drug

Porous Electrospun Fibers with Self-Sealing Functionality: an Enabling Strategy for Trapping Biomacromolecules.